NCT06880926 is a Phase 2 clinical trial of Krill oil in Osteoarthritis (OA) of the Knee, sponsored by Qilu Hospital of Shandong University.

Who is sponsoring NCT06880926?

NCT06880926 is sponsored by Qilu Hospital of Shandong University.

What drugs are being tested in NCT06880926?

Interventions in NCT06880926: Krill oil, Olive Oil.

What condition does NCT06880926 study?

NCT06880926 studies Osteoarthritis (OA) of the Knee, Osteoarthritis Knee Pain.

Is NCT06880926 still recruiting?

NCT06880926 is currently not yet recruiting. Last updated 18 March 2025.

Last reviewed 2025-03-18 · How we verify

NCT06880926

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antarctic Krill Oil for Knee Osteoarthritis Pain

Not yet recruiting Phase 2 Last updated 18 March 2025

What this trial tests

Phase 2 trial testing Krill oil in Osteoarthritis (OA) of the Knee in 116 participants. Not yet recruiting.

Timeline

1 April 2025

Primary endpoint
28 February 2026

28 February 2026

Quick facts

Lead sponsor	Qilu Hospital of Shandong University
Phase	Phase 2
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	116
Start date	1 April 2025
Primary completion	28 February 2026
Estimated completion	28 February 2026

Drugs / interventions tested

Krill oil — full drug profile →
Olive Oil — full drug profile →

Conditions studied

Osteoarthritis (OA) of the Knee — all drugs for Osteoarthritis (OA) of the Knee →
Osteoarthritis Knee Pain — all drugs for Osteoarthritis Knee Pain →

Sponsor

Qilu Hospital of Shandong University

Who can join

Adults 45 to 75, any sex, with Osteoarthritis (OA) of the Knee or Osteoarthritis Knee Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the effectiveness and safety of Antarctic Krill Oil (AKO) as a dietary supplement in managing pain associated with knee osteoarthritis (OA). The main questions it aims to answer are: ①Does AKO reduce daily pain intensity in participants with moderate knee OA? ②What adverse effects do participants experience when taking AKO? Researchers will conduct a randomized, double-blind study comparing AKO to a placebo (identical appearance without active components) to assess: * Changes in joint pain severity; ②Functional improvement in daily activities; ③Biochemical safety parameters,etc.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Krill oil

Trials testing the same drug.

NCT06939244 — Investigating the Effects of Krill Oil on the Recovery From Muscle Damaging Exercise: a Randomised Controlled Trial · NA · recruiting
NCT06580912 — Krill Oil for Pain in Elders · Phase 2 · completed
NCT05869513 — Krill Oil and Resistance Exercise in Older Adults · NA · completed
NCT05774444 — Investigating the Effects of Krill Oil and Krill Protein on Post-exercise Muscle Protein Metabolism · NA · recruiting
NCT05677074 — Do Patients With Fish or Shellfish Allergy Tolerate the Consumption of Fish Oil Supplements? A Clinical Study · NA · completed

Other recruiting trials for Osteoarthritis (OA) of the Knee

Currently open trials in the same condition.

NCT07231471 — Platelet Rich Plasma for Musculoskeletal Conditions · NA · recruiting
NCT06929871 — Mako Cementless TKA vs Mako Cemented TKA · NA · recruiting
NCT06865079 — 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femo · Phase 2 · active not recruiting
NCT06702046 — The Efficacy of Transcutaneous Pulsed Radiofrequency Acupuncture for Knee Osteoarthritis · NA · recruiting
NCT06805188 — Clinical Study of Acupuncture Treatment of Knee Osteoarthritis · NA · recruiting

Other Qilu Hospital of Shandong University trials

Trials by the same sponsor.

NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
NCT07140419 — Coronary Computed Tomographic Angiography Combined With CT-FFR in Intermediate-Risk Chest Pain Patients. · NA · not yet recruiting
NCT07509879 — Research on the Molecular Mechanism of Cognitive Differences Between Williams Syndrome and Autism Spectrum Disorder · not yet recruiting
NCT07537374 — A Case-Control Observational Study of Peripheral Blood-Derived iPSC Models to Investigate Oligodendrocyte Lineage Develo · not yet recruiting
NCT07505940 — Bilateral Comparison of Unilateral Sacral Neuromodulation Test Stimulation in the Treatment of Neurogenic Bladder · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06880926 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Qilu Hospital of Shandong University
Last refreshed: 18 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06880926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing